Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

47
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
47
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.2K
The pathophysiology of pneumonia involves the following steps:
4.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019.

Open forum infectious diseases·2022
Same author

How low can we go in community-acquired pneumonia therapy?

Lancet (London, England)·2021
Same author

Consensus (Convergence of Opinion on Recommendations and Evidence [CORE]) Versus Systematic (Grading of Recommendations Assessment, Development, and Evaluation [GRADE]) Approach to Development of Guidelines for Community-acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Aspiration Pneumonia. Reply.

The New England journal of medicine·2019
Same author

Aspiration Pneumonia.

The New England journal of medicine·2019
Same author

Something New for Community-Acquired Pneumonia?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2016

Related Experiment Video

Updated: Apr 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.8K

Community-acquired pneumonia: An overview.

Lionel A Mandell1

  • 1Department of Medicine, Division of Infectious Diseases, McMaster University , Hamilton, Ontario , Canada.

Postgraduate Medicine
|July 31, 2015
PubMed
Summary

Community-acquired pneumonia (CAP) poses significant health risks and is often misdiagnosed. Early antimicrobial treatment and supportive care, guided by national guidelines, are crucial for managing CAP effectively.

Keywords:
Community-acquired pneumoniaadjunctive therapyguidelinespneumococcussite of carevaccines

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.6K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.4K

Related Experiment Videos

Last Updated: Apr 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.8K
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.6K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.4K

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Community-acquired pneumonia (CAP) remains a major cause of illness and death.
  • Accurate diagnosis and timely treatment of CAP are often challenging due to diverse pathogens.
  • The choice of care setting and diagnostic approach significantly impacts patient outcomes.

Purpose of the Study:

  • To review current understanding and management strategies for community-acquired pneumonia.
  • To highlight challenges in pathogen identification and initial antimicrobial selection for CAP.
  • To discuss the role of adjunctive therapies and emerging treatment considerations in CAP.

Main Methods:

  • Review of existing literature and national guidelines on CAP management.
  • Analysis of common pathogens responsible for CAP, including typical and atypical bacteria.
  • Discussion of evidence supporting early antimicrobial administration and site-of-care decisions.

Main Results:

  • Common CAP pathogens include Streptococcus pneumoniae, atypical bacteria (Mycoplasma, Chlamydophila), Staphylococcus aureus, and Gram-negative rods.
  • Prompt initiation of antimicrobial therapy is vital, especially for hospitalized patients.
  • Adjunctive therapies, such as fluid replacement, pressors, macrolides (due to immunomodulatory effects), and potentially steroids, show promise.

Conclusions:

  • Effective CAP management requires prompt, guideline-directed antimicrobial therapy.
  • Adjunctive treatments may improve outcomes in CAP patients.
  • Further research into the role of steroids and immunomodulatory agents in CAP is warranted.